4.6 based on 5 reviewsView this provider's reviews
Patient satisfaction ratings and reviews are based on personal opinions. Before you choose any doctor you should take into account their background, training, specialized experience AND their patient satisfaction to ensure they are the right fit for you.
Kara Kelly, MD is a pediatric oncologist with special expertise in the care of children and adolescents with leukemia and lymphoma, particularly acute lymphoblastic leukemia and Hodgkin lymphoma. She also collaborates with the Center for Comprehensive Wellness, which provides integrative and complementary medicine approaches to help relieve patients' symptoms during therapy and to improve the quality of life for them and their families. Examples of complementary medicine include massage therapy, reflexology, acupuncture and acupressure, Reiki and therapeutic touch, exercise and yoga, aromatherapy, and mind-body techniques such as meditation and guided imagery. Dr. Kelly co-authored a book for patients called Integrative Strategies for Cancer Patients (World Scientific Publishing, 2012) to help patients integrate these approaches on their own. Dr. Kelly enjoys taking care of patients who have medically challenging conditions, seeing them through treatment and supporting them through the years that follow. The relationships she forms with her patients and their families are often long-lasting, and it inspires her when she sees them get better and go on to lead normal, productive lives. Dr. Kelly also leads clinical research studies aimed at developing new therapies for pediatric cancers that are associated with a lower risk of cancer relapse and fewer short-term and long-term side effects. She chairs the COG Hodgkin Lymphoma Committee and also directs large, COG-sponsored national clinical trials to improve the care of patients with high-risk Hodgkin lymphoma. While many new drugs for cancer are being developed, pediatric cancer specialists are looking for the best ways to combine new drugs with existing therapies to improve the outcomes of patients being treated while reducing long-term toxicities, such as late complications of radiation therapy.